Authors:
PRINSSEN HM
MOLTHOFF CFM
VERHEIJEN RHM
BROADHEAD TJ
KENEMANS P
ROOS JC
DAVIES Q
VANHOF AC
FRIER M
DENHOLLANDER W
WILHELM AJ
BAKER TS
SOPWITH M
SYMONDS EM
PERKINS AC
Citation: Hm. Prinssen et al., BIODISTRIBUTION OF IN-111-LABELED ENGINEERED HUMAN-ANTIBODY CTM01 (HCTM01) IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PRIOR ADMINISTRATION OF UNLABELED HCTM01, Cancer immunology and immunotherapy, 47(1), 1998, pp. 39-46
Authors:
MOLTHOFF CFM
PRINSSEN HM
KENEMANS P
VANHOF AC
DENHOLLANDER W
VERHEIJEN RHM
Citation: Cfm. Molthoff et al., ESCALATING PROTEIN DOSES OF CHIMERIC MONOCLONAL-ANTIBODY MOV18 IMMUNOGLOBULIN-G IN OVARIAN-CARCINOMA PATIENTS - A PHASE-I STUDY, Cancer, 80(12), 1997, pp. 2712-2720
Authors:
VANHOF AC
MOLTHOFF CFM
DAVIES Q
PERKINS AC
VERHEIJEN RHM
KENEMANS P
DENHOLLANDER W
WILHELM AJ
BAKER TS
SOPWITH M
FRIER M
SYMONDS EM
ROOS JC
Citation: Ac. Vanhof et al., BIODISTRIBUTION OF (111)INDIUM-LABELED ENGINEERED HUMAN-ANTIBODY CTMO1 IN OVARIAN-CANCER PATIENTS - INFLUENCE OF PROTEIN DOSE, Cancer research, 56(22), 1996, pp. 5179-5185